All In MedTech

Device Trial Radar · NCT05874128

PROSPECTIVE EVALUATION OF HEARTFOCUS

PROSPECTIVE EVALUATION OF HEARTFOCUS: A SOFTWARE SUPPORTING THE ACQUISITION OF CARDIAC ULTRASOUND EXAMS (HF-01)

Last checked: Nov 20, 2026Latest source record: Jan 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

240

Actual

Start

Nov 13, 2023

Primary completion

Aug 16, 2024

Study completion Aug 16, 2024

Sponsor

Lead sponsor
DESKiNot on our public-company list
Sponsor type
Industry
First posted
May 24, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study's objective is to evaluate if exams, performed with the HeartFocus software by novices, are of sufficient quality to visually analyze the left ventricular size, the left ventricular function, the right ventricular size, and the presence of non-trivial pericardial effusion. Novices will be nurses without prior ultrasound experience who have received dedicated training on cardiac ultrasound and on Heartfocus software. Ultrasound exams will be limited to the acquisition of 10 reference views

Conditions

  • Cardiac Disease

Interventions

  • Using HeartFocus software with AI guidance (Novices)Device

    The novice are nurses without prior ultrasound experience performed limited echocardiograms using the HeartFocus AI-based guidance software (DESKi). After a half-day training and practice on ≤9 patients, each novice acquired echocardiographic clips for 10 standard transthoracic views with the assistance of real-time software guidance and automated recording.

  • Using HeartFocus software without AI-guidanceDevice

    Experienced sonographers and cardiologists performed limited echocardiograms using HeartFocus software, without AI assistance. The experts acquired echocardiographic sequences corresponding to the 10 standard transthoracic views, just like the novices.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Left Ventricular Size (Qualitative Visual Assessment)Time frame: Images evaluated by the cardiologists after the acquisition
  2. The Left Ventricular Function (Qualitative Visual Assessment)Time frame: Images evaluated by the cardiologists after the acquisition
  3. The Right Ventricle Size (Qualitative Visual Assessment)Time frame: Images evaluated by the cardiologists after the acquisition

1 more outcomes with a free account

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Lenox Hill Hospital

    New York, New York

  • University Hospital of Bordeaux

    Bordeaux, Aquitaine, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.